# FEMSelect

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/femselect

- Industry: Medical Devices & Equipment
- Headquarters: Israel
- Website: www.femselect.com
- Total disclosed funding: $12M
- Latest round: Series B (May 13, 2025)
- Investors on record: 12

## About

Founded in 2012 and based in Israel by Menahem Neuman, FEMSelect Ltd. is a developer of a pelvic floor ligament attachment method to prevent the sagging or falling of the female pelvic organs. As of 2022, Debbie Garner and Renee Selman are the co-CEOs of the company. In October 2022, FEMSelect Ltd. raised USD 9 million in Series B funding from New Age Ventures and TriVentures, including Keiretsu Capital, Keiretsu Forum Mid-Atlantic, MEDA Angels, RAD BioMed, Robin Hood Ventures, and TransPacific Venture Partners. The company also has an office in the US.

The company offers EnPlace®, a delivery technology that allows for precise guidance, insertion, and deployment of the anchor unit. EnPlace® is a minimally invasive surgical system that does not require any deep dissection or mesh and is made up of a Nitinol-based anchor, surgical sutures, and a unique attaching mechanism.

The organization plans to use the October 2022 funding to accelerate EnPlace®, primarily in the US, and to support its growth.

## Funding rounds

- Series B, May 13, 2025 — Robin Hood Ventures, Terra Verde Partners, Triventures, RAD BioMed, New Age Ventures, Nordwand Capital, Avea Ventures
- Series B, Oct 19, 2022, $9M — Robin Hood Ventures, Triventures, Mid Atlantic Bio Angels, TransPacific Venture Partners, RAD BioMed, Keiretsu Capital, New Age Ventures, Keiretsu Forum Mid-Atlantic, MEDA Angels
- Series A, Mar 13, 2018, $3M — Mid Atlantic Bio Angels

## Investors

- Mid Atlantic Bio Angels (https://capitalatlas.ai/funds/mid-atlantic-bio-angels) — Series A, Series B
- Robin Hood Ventures (https://capitalatlas.ai/funds/robin-hood-ventures) — Series B
- Triventures (https://capitalatlas.ai/funds/triventures) — Series B
- TransPacific Venture Partners (https://capitalatlas.ai/funds/transpacific-venture-partners) — Series B
- RAD BioMed (https://capitalatlas.ai/funds/rad-biomed) — Series B
- Keiretsu Capital (https://capitalatlas.ai/funds/keiretsu-capital) — Series B
- New Age Ventures (https://capitalatlas.ai/funds/new-age-ventures) — Series B
- Keiretsu Forum Mid-Atlantic — Series B
- MEDA Angels (https://capitalatlas.ai/funds/meda-angels) — Series B
- Terra Verde Partners (https://capitalatlas.ai/funds/terra-verde-partners) — Series B
- Nordwand Capital (https://capitalatlas.ai/funds/nordwand-capital) — Series B
- Avea Ventures — Series B